1
-
1
of
1
results (0.59 seconds)
Sort By:
-
Genomic Testing: Cost-Saving or Cost-Inflating for Payers?
Genomic Testing: Cost-Saving or Cost-Inflating for Payers? As private payers ponders ... treatment pathways, can personalized approaches to care prove financially sound? cancer;health economics;Return ...- Authors: Didier Serre
- Date: Feb 2018
- Competency: External Forces & Industry Knowledge>Actuarial methods in business operations; Results-Oriented Solutions>Assess decision effectiveness
- Publication Name: Health Watch
- Topics: Health & Disability>Health care